Published in J Infect Dis on September 01, 1983
The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol Infect (1993) 2.07
Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. J Clin Microbiol (1991) 1.89
Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus. J Clin Microbiol (1987) 1.28
Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles. J Clin Microbiol (1986) 1.27
Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus. Antimicrob Agents Chemother (1985) 1.13
Comparison of latex agglutination test with enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus. J Clin Microbiol (1993) 0.95
Cellular and humoral immune abnormalities in Gulf War veterans. Environ Health Perspect (2004) 0.92
Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group. Arch Dis Child (2000) 0.87
Herpes zoster laryngitis: case report and serological profile. Eur Arch Otorhinolaryngol (2006) 0.85
Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency. Clin Exp Immunol (2015) 0.83
Anti-bovine antibody in human sera as a cause of nonspecificity in enzyme immunoassay. J Clin Microbiol (1987) 0.79
Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus. J Virol (1987) 0.78
Establishment by enzyme-linked immunosorbent assay of seronegative range for herpes simplex virus and cytomegalovirus antibodies and evaluation of heterologous responses to live varicella vaccine. J Clin Microbiol (1988) 0.76
Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay. Sci Rep (2016) 0.75
Comparison of three commercially available assays for detection of varicella-zoster virus antibody. Clin Diagn Lab Immunol (1994) 0.75
Varicella vaccination in children with lymphoma and solid tumours. Postgrad Med J (2006) 0.75
Enzyme-linked immunosorbent assay for detection of antibody to human herpesvirus 6. Clin Diagn Lab Immunol (1997) 0.75
Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis (1974) 4.41
Measles outbreak in a fully immunized secondary-school population. N Engl J Med (1987) 2.75
Prevention of varicella by zoster immune globulin. N Engl J Med (1969) 2.57
Separation of infectious Varicella-Zoster virus from human embryonic lung fibroblasts. Virology (1967) 1.85
Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol (1979) 1.64
Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA (1983) 1.60
Zoster immune globulin. A further assessment. N Engl J Med (1974) 1.57
Observations on the growth of varicella-zoster virus in human diploid cells. J Gen Virol (1973) 1.48
Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol (1984) 1.47
Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster. J Infect Dis (1975) 1.47
Recent advances in varicella-zoster virus infection. Ann Intern Med (1999) 1.41
Chickenpox--examining our options. N Engl J Med (1991) 1.41
Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis (1979) 1.40
Lack of evidence of transmission of HIV-1 to family contacts of HIV-1 infected children. Clin Pediatr (Phila) (1998) 1.40
Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study. Pediatr Infect Dis J (1996) 1.28
Zoster, reinfection or activation of latent virus? Observations on the antibody response. Am J Med (1970) 1.28
Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles. J Clin Microbiol (1986) 1.27
Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics (1986) 1.19
Prevention of varicella in high risk children: a collaborative study. Pediatrics (1972) 1.16
Passive immunization against varicella-zoster infections and other modes of therapy. J Infect Dis (1973) 1.15
Effect of early immunization on antibody response to reimmunization with measles vaccine as demonstrated by enzyme-linked immunosorbent assay (ELISA). Pediatrics (1984) 1.12
Varicella-zoster infections in pregnancy. JAMA (1967) 1.08
Steroid therapy and varicella. J Pediatr (1972) 1.08
Safe handling of vaccines. Pediatrics (1991) 1.03
Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age. J Pediatr (1987) 1.03
Unrecognized human immunodeficiency virus type 1 infection in a cohort of transfused neonates: a retrospective investigation. Pediatrics (1995) 1.03
Impact of revaccinating children who initially received measles vaccine before 10 months of age. Pediatrics (1986) 1.00
Shedding and survival of herpes simplex virus from 'fever blisters'. Pediatrics (1982) 1.00
Children hospitalized for varicella: a prevaccine review. J Pediatr (1996) 0.99
Varicella vaccine--where are we? Pediatrics (1986) 0.99
Zoster in infancy: failure to maintain virus latency following intrauterine infection. J Pediatr (1981) 0.96
Administration of live varicella vaccine to children wtih leukaemia. Lancet (1982) 0.95
Fetal and neonatal varicella-zoster infections. Semin Perinatol (1983) 0.95
Epidemiological standardization of a test for susceptibility to mumps. J Infect Dis (1984) 0.93
Measles control in the United States: problems of the past and challenges for the future. Clin Microbiol Rev (1995) 0.91
Mycoplasma, amnionitis, and respiratory distress syndrome. JAMA (1969) 0.90
Evaluation of the pertussis components of diphtheria-tetanus-pertussis vaccine. Pediatrics (1983) 0.89
Evaluation of a live attenuated mumps vaccine (Jeryl Lynn). With observations on the optimal time for testing serologic response. Am J Dis Child (1969) 0.88
Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia. Pediatrics (1987) 0.86
Management of varicella exposure in a neonatal intensive care unit. JAMA (1989) 0.86
Commentary: protection against varicella. Pediatrics (1977) 0.85
Herpes zoster in children with acute lymphocytic leukemia. Am J Dis Child (1988) 0.85
Susceptibility of hospital personnel to varicella-zoster virus. J Infect Dis (1984) 0.85
Outbreak of varicella in a newborn intensive care nursery. Am J Dis Child (1984) 0.84
Complex atrial tachycardias and respiratory syncytial virus infections in infants. J Pediatr (1994) 0.83
Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response. J Infect Dis (1987) 0.83
Placental transfer of varicella-zoster antibody. Pediatrics (1966) 0.82
Bivalent influenza vaccine in children with cancer. J Infect Dis (1977) 0.81
Varicella in day care centers. Rev Infect Dis (1986) 0.80
Varicella-zoster virus vaccine. JAMA (1978) 0.80
Herpes simplex infection of the newborn. Am J Dis Child (1972) 0.80
Visceral involvement by herpes simplex virus in eczema herpeticum. Am J Dis Child (1968) 0.80
Should patients with zoster receive zoster immune globulin? JAMA (1975) 0.80
Anti-bovine antibody in human sera as a cause of nonspecificity in enzyme immunoassay. J Clin Microbiol (1987) 0.79
Parotitis in children who had previously received mumps vaccine. Pediatrics (1972) 0.79
Ineffectiveness of isolation of patients as a method of preventing the spread of mumps. Failure of the mumps skin-test antigen to predict immune status. N Engl J Med (1968) 0.79
Rapid diagnosis of varicella-zoster infections by agar-gel diffusion. J Infect Dis (1972) 0.79
Varicella vaccine: the crossroads is where we are not! Pediatrics (1978) 0.78
Complete spectrum of the varicella congenital defects syndrome in 5-year-old child. Pediatr Infect Dis (1984) 0.78
Abscess in newborn infants caused by Mycoplasma. Pediatrics (1970) 0.78
Zoster in children. Am J Dis Child (1968) 0.78
Virus burden in human immunodeficiency virus type 1-infected children: relationship to disease status and effect of antiviral therapy. Pediatrics (1991) 0.78
Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants. J Infect Dis (1987) 0.77
Adrenal response in children receiving high doses of ketoconazole for systemic coccidioidomycosis. J Pediatr (1988) 0.76
Interview with Philip A. Brunell: contagion and varicella-zoster virus. Pediatr Infect Dis (1983) 0.76
Absence of viremia in primary herpetic gingivostomatitis. Pediatr Infect Dis (1984) 0.76
Possible mechanisms for maintaining immunity to varicella-zoster virus. Clinical observations. Am J Dis Child (1970) 0.76
Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children. Am J Dis Child (1993) 0.76
American Academy of Pediatrics Committee on Infectious Diseases: Prevention of hepatitis B virus infections. Pediatrics (1985) 0.76
Establishment by enzyme-linked immunosorbent assay of seronegative range for herpes simplex virus and cytomegalovirus antibodies and evaluation of heterologous responses to live varicella vaccine. J Clin Microbiol (1988) 0.76
Inhibition of oral shedding of herpes simplex virus by cytosine arabinoside. J Infect Dis (1973) 0.75
The antigens of varicella-zoster virus. J Immunol (1972) 0.75
Varicella vaccine update. West J Med (1988) 0.75
A gel-precipitin test for the diagnosis of varicella. Bull World Health Organ (1971) 0.75
Enzyme-linked immunosorbent assay for detection of antibody to human herpesvirus 6. Clin Diagn Lab Immunol (1997) 0.75
Immunization practice--1983. Trans Assoc Life Insur Med Dir Am (1985) 0.75
Group B streptococcal urinary tract infection in an infant. JAMA (1979) 0.75
Oral acyclovir treatment of chickenpox in normal adolescents. J Pediatr (1992) 0.75
Prevention of pertussis, Haemophilus and varicella infections. Pediatr Infect Dis (1985) 0.75
Effectiveness of modified release isosorbide mononitrate affected by incorrect use. BMJ (2000) 0.75
Mumps antibody: placental transfer and disappearance during the first year of life. Pediatrics (1970) 0.75
Non-streptococcal pharyngitis. Pediatr Infect Dis (1985) 0.75
Meningoencephalitis in a neonate congenitally infected with human immunodeficiency virus type 1. J Pediatr (1992) 0.75
Managing childhood chickenpox: cost implications. Pharmacoeconomics (1993) 0.75
Propagation of varicella-zoster virus in a diploid strain of embryonic thyroid cells from the rhesus monkey. J Infect Dis (1972) 0.75
A new technique for staining cover slips for fluorescence microscopy. Appl Microbiol (1967) 0.75
Prevention of pertussis--are we failing? Pediatrics (1985) 0.75
Pneumonia in the neonatal intensive care unit. Diagnosis by quantitative bacterial tracheal aspirate cultures. J Perinatol (1994) 0.75
Administration of varicella vaccine to children with leukemia. Biken J (1984) 0.75
Letter: Zoster immune globulin shortage! Pediatrics (1974) 0.75
Enteroviral infections. Pediatr Infect Dis (1985) 0.75
Effect of live attenuated mumps vaccine virus on the expression of tuberculin sensitivity. J Pediatr (1972) 0.75
American Academy of Pediatrics. Committee on Infectious Diseases. Recommendations for using pneumococcal vaccine in children. Pediatrics (1985) 0.75
Management of neonates born to mothers with group B streptococcus colonization. J Perinatol (1997) 0.75
Effect of the antiviral drug, cytosine arabinoside, on the developing nervous system. Pediatr Res (1974) 0.75
Childhood infectious diseases in adults. Tex Med (1981) 0.75
Varicella-zoster virus infection of diploid and chemically transformed guinea-pig embryo cells: factors influencing virus replication. J Gen Virol (1981) 0.75